CONTEXT: Chronic starvation is characterized by GH resistance, and obesity is characterized by decreased GH secretion. In both extremes, IGF1 levels may be low and androgen levels may be abnormal. OBJECTIVE: To investigate the determinants of IGF1 and GH across the weight spectrum in women. DESIGN: Cross-sectional study. SETTING: Clinical research center. STUDY PARTICIPANTS: In total, 32 women had participated in the study: 11 women with anorexia nervosa (AN), 11 normal-weight women, and 10 obese women of comparable mean age. INTERVENTION: None. MAIN OUTCOME MEASURES: Pooled hourly overnight serum samples assayed for IGF1, GH, estradiol (E(2)), testosterone, SHBG, insulin, free fatty acids, and trunk fat. RESULTS: Free testosterone was higher in obese women and lower in women with AN than in normal-weight women, and was the only independent (and positive) predictor of IGF1 levels, accounting for 14% of the variability (P=0.032) in the group as a whole. This relationship was stronger when obese women were excluded, with free testosterone accounting for 36% of the variability (P=0.003). Trunk fat accounted for 49% of the variability (P<0.0001) of GH, with an additional 7% of the variability attributable to E(2) (P=0.042) in the group as a whole, but was not a significant determinant of GH secretion when obese women were excluded. CONCLUSIONS: Free testosterone is a significant determinant of IGF1 levels in women across the body weight spectrum. In contrast, GH secretion is differentially regulated at the extremes of the weight spectrum.
CONTEXT: Chronic starvation is characterized by GH resistance, and obesity is characterized by decreased GH secretion. In both extremes, IGF1 levels may be low and androgen levels may be abnormal. OBJECTIVE: To investigate the determinants of IGF1 and GH across the weight spectrum in women. DESIGN: Cross-sectional study. SETTING: Clinical research center. STUDY PARTICIPANTS: In total, 32 women had participated in the study: 11 women with anorexia nervosa (AN), 11 normal-weight women, and 10 obesewomen of comparable mean age. INTERVENTION: None. MAIN OUTCOME MEASURES: Pooled hourly overnight serum samples assayed for IGF1, GH, estradiol (E(2)), testosterone, SHBG, insulin, free fatty acids, and trunk fat. RESULTS:Free testosterone was higher in obesewomen and lower in women with AN than in normal-weight women, and was the only independent (and positive) predictor of IGF1 levels, accounting for 14% of the variability (P=0.032) in the group as a whole. This relationship was stronger when obesewomen were excluded, with free testosterone accounting for 36% of the variability (P=0.003). Trunk fat accounted for 49% of the variability (P<0.0001) of GH, with an additional 7% of the variability attributable to E(2) (P=0.042) in the group as a whole, but was not a significant determinant of GH secretion when obesewomen were excluded. CONCLUSIONS:Free testosterone is a significant determinant of IGF1 levels in women across the body weight spectrum. In contrast, GH secretion is differentially regulated at the extremes of the weight spectrum.
Authors: James Gibney; Troels Wolthers; Gudmundur Johannsson; A Margot Umpleby; Ken K Y Ho Journal: Am J Physiol Endocrinol Metab Date: 2005-02-22 Impact factor: 4.310
Authors: K K Miller; E A Lawson; V Mathur; T L Wexler; E Meenaghan; M Misra; D B Herzog; A Klibanski Journal: J Clin Endocrinol Metab Date: 2007-02-06 Impact factor: 5.958
Authors: Andrea L Utz; Elizabeth A Lawson; Madhusmita Misra; Diane Mickley; Suzanne Gleysteen; David B Herzog; Anne Klibanski; Karen K Miller Journal: Bone Date: 2008-03-25 Impact factor: 4.398
Authors: Alia A Hussain; Christopher Hübel; Mathias Hindborg; Emilie Lindkvist; Annie M Kastrup; Zeynep Yilmaz; René K Støving; Cynthia M Bulik; Jan M Sjögren Journal: Int J Eat Disord Date: 2019-03-28 Impact factor: 4.861
Authors: José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal Journal: Gastroenterology Date: 2013-12-06 Impact factor: 22.682
Authors: Laura E Dichtel; Elizabeth A Lawson; Melanie Schorr; Erinne Meenaghan; Margaret Lederfine Paskal; Kamryn T Eddy; Graziano Pinna; Marianela Nelson; Ann M Rasmusson; Anne Klibanski; Karen K Miller Journal: Neuropsychopharmacology Date: 2017-11-01 Impact factor: 7.853
Authors: T G Goetz; N Nair; S Shiau; R R Recker; J M Lappe; D W Dempster; H Zhou; B Zhao; X Guo; W Shen; T L Nickolas; M Kamanda-Kosseh; M Bucovsky; J Stubby; E Shane; A Cohen Journal: Osteoporos Int Date: 2021-10-19 Impact factor: 4.507
Authors: Johannes D Veldhuis; Roy B Dyer; Sergey A Trushin; Olga P Bondar; Ravinder J Singh; George G Klee Journal: Metabolism Date: 2014-03-21 Impact factor: 8.694